New York Community Capital Trust V
Change company Symbol lookup
Select an option...
NYCB-U New York Community Capital Trust V
CZR Caesars Entertainment Inc
NFLX Netflix Inc
REGN Regeneron Pharmaceuticals Inc
NSC Norfolk Southern Corp
WM Waste Management Inc
ITOS Iteos Therapeutics Inc
CCLD CareCloud Inc
JEF Jefferies Financial Group Inc
RSASF Resaas Services Inc
Go

Closing Price
$44.38
Day's Change
-0.285 (-0.64%)
Bid
--
Ask
--
B/A Size
--
Day's High
44.60
Day's Low
43.66
Volume
(Below Average)
Volume:
3,891

10-day average volume:
4,842
3,891

CLASS ACTION UPDATE for PLTR, CNTA and SEDG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

11:30 am ET November 10, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / November 10, 2022 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

PLTR Shareholders Click Here: https://www.zlk.com/pslra-1/palantir-lawsuit-loss-submission-form?prid=33555&wire=1

CNTA Shareholders Click Here: https://www.zlk.com/pslra-1/centessa-pharmaceuticals-loss-submission-form?prid=33555&wire=1

SEDG Shareholders Click Here: https://www.zlk.com/pslra-1/solaredge-class-action-submission-form?prid=33555&wire=1

* ADDITIONAL INFORMATION BELOW *

Levi & Korsinsky, LLP, Thursday, November 10, 2022, Press release picture

Palantir Technologies Inc. (NYSE:PLTR)

This lawsuit is on behalf of all purchasers of Class A common stock during the period September 30, 2020 to August 5, 2022, including purchases pursuant and/or traceable to documents used in connection with the offer, sale, and direct listing of Palantir Class A common stock on the New York Stock Exchange beginning on or about September 30, 2020.

Lead Plaintiff Deadline : November 14, 2022

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/palantir-lawsuit-loss-submission-form?prid=33555&wire=1

According to the filed complaint, (i) Palantir's investments in marketable securities were having a significant negative impact on the Company's earnings per share ("EPS") results; (ii) Palantir overstated the sustainability of its government segment's growth and revenues; (iii) Palantir was experiencing a significant slowdown in revenue growth, particularly among its government customers, despite ongoing global conflicts and market disruptions; (iv) as a result of all the foregoing, the Company was likely to miss consensus estimates for its first quarter 2022 EPS and second quarter 2022 sales outlook; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Centessa Pharmaceuticals plc (NASDAQ:CNTA)

This lawsuit is on behalf of a class consisting of persons and entities that purchased or otherwise acquired: (a) Centessa American Depositary Shares pursuant and/or traceable to documents issued in connection with the Company's initial public offering conducted on or about May 28, 2021; and/or (b) Centessa securities between May 28, 2021 and June 1, 2022.

Lead Plaintiff Deadline : November 28, 2022

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/centessa-pharmaceuticals-loss-submission-form?prid=33555&wire=1

According to the filed complaint, (i) the Company's product, lixivaptan, was less safe than defendants had represented; (ii) defendants overstated lixivaptan's clinical and commercial prospects; (iii) another Centessa product, ZF874, was less safe than defendants had represented; (iv) defendants overstated ZF874's clinical and commercial prospects while downplaying the drug's safety issues; and (v) as a result, documents issued in connection with Centessa's initial public offering and the Company's public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.

SolarEdge Technologies, Inc. (NASDAQ:SEDG)

This lawsuit is on behalf of a class consisting of persons who purchased or otherwise acquired common shares of SolarEdge stock between August 6, 2022 to October 19, 2022, both dates inclusive.

Lead Plaintiff Deadline : January 3, 2023

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/solaredge-class-action-submission-form?prid=33555&wire=1

According to the filed complaint, (i) the designs of the power optimizers, inverters, and components thereof used to develop SolarEdge's products potentially originated with and were misappropriated from Ampt LLC ("Ampt"), a competitor in the renewable energy industry; (ii) Ampt made claims against the Company for misappropriating Ampt's patented technology, (iii) evidentiary support existed for the allegations that SolarEdge misappropriated certain patents relating to the design and development of the Company's power optimizers and inverters; (iv) as a result, SolarEdge faced a threat of regulatory and/or court action, which could prohibit the import, marketing, and sale of its power optimizers and inverters, including solar energy systems that contain such products; which in turn (v) seriously threatened SolarEdge's ability to monetize on their solar energy systems that contain the power optimizers and inverters in the United States and generate revenue; and (vi) certain revenues generated from the sale of power optimizers and inverters were potentially based on SolarEdge's unlawful activities, including the misappropriation of patented designs by Ampt.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Eduard Korsinsky, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

SOURCE : Levi & Korsinsky, LLP





View source version on accesswire.com:

https://www.accesswire.com/725040/CLASS-ACTION-UPDATE-for-PLTR-CNTA-and-SEDG-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders



comtex tracking

COMTEX_418559047/2457/2022-11-10T11:30:21

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.